Opioid System Reorganizes After Spinal Cord Injury to Cause Urinary Retention

Naloxone restored bladder function in chronic but not acute spinal cord-injured cats, showing the opioid system reorganizes over time to contribute to urinary retention.

Thor, K B et al.·Neuroreport·1994·Preliminary EvidenceAnimal StudyAnimal Study
RPEP-00310Animal StudyPreliminary Evidence1994RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Naloxone restored urinary function in chronic spinal cats but not acute ones, demonstrating opioid system plasticity that contributes to urinary retention after spinal cord injury.

Key Numbers

How They Did This

Researchers administered naloxone (5-500 micrograms/kg i.p.) to unanesthetized paraplegic cats with acute or chronic spinal cord injuries while monitoring bladder function and hind limb reflexes.

Why This Research Matters

Urinary problems are a major complication of spinal cord injury. Finding that the opioid system plays an increasing role over time suggests a treatable target for improving bladder function in people with chronic paralysis.

The Bigger Picture

Urinary complications are one of the most debilitating consequences of spinal cord injury. Finding that the opioid system contributes — and that it's time-dependent — points to a window for intervention.

What This Study Doesn't Tell Us

Animal study in cats. The opioid system reorganization may differ between cats and humans. Only tested naloxone (a non-selective opioid blocker), so the specific receptor subtypes involved are unknown.

Questions This Raises

  • ?Could opioid antagonists be used clinically for neurogenic bladder?
  • ?At what time point does the opioid reorganization become significant?

Trust & Context

Key Stat:
Chronic only Naloxone improved bladder function in chronic but not acute spinal injury — showing progressive opioid system reorganization
Evidence Grade:
Preliminary — animal study in cats. Important clinical observation but limited species and small numbers.
Study Age:
Published in 1994 (32 years ago). Neurogenic bladder management continues to be a major challenge in spinal cord injury.
Original Title:
Plasticity in spinal opioid control of lower urinary tract function in paraplegic cats.
Published In:
Neuroreport, 5(13), 1673-8 (1994)
Database ID:
RPEP-00310

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

Why does spinal cord injury cause bladder problems?

The spinal cord carries signals between the brain and bladder. After injury, these pathways are disrupted. This study shows the spinal opioid system gradually adapts to further suppress bladder function over time.

Could opioid blockers help paralyzed patients urinate?

This study suggests yes — naloxone improved bladder function in chronically injured cats. Clinical trials would be needed, but it points to a potential new treatment for neurogenic bladder.

Read More on RethinkPeptides

Cite This Study

RPEP-00310·https://rethinkpeptides.com/research/RPEP-00310

APA

Thor, K B; Roppolo, J R; Kawatani, M; Erdman, S; deGroat, W C. (1994). Plasticity in spinal opioid control of lower urinary tract function in paraplegic cats.. Neuroreport, 5(13), 1673-8.

MLA

Thor, K B, et al. "Plasticity in spinal opioid control of lower urinary tract function in paraplegic cats.." Neuroreport, 1994.

RethinkPeptides

RethinkPeptides Research Database. "Plasticity in spinal opioid control of lower urinary tract f..." RPEP-00310. Retrieved from https://rethinkpeptides.com/research/thor-1994-plasticity-in-spinal-opioid

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.